Archive for February 18, 2022
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
September 28, 2022: The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated section are summarized below: Monkeypox: Added links to useful government and professional association websites.For a list of recent updates, please…
Read MoreUpdates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
October 11, 2022: The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has made revisions in the following sections of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection to address U.S. Food and Drug Administration approval of the dispersible tablet formulation of the fixed-dose combination…
Read MoreImportant message for Ryan White HIV/AIDS Program (Ryan White HIV/AIDS Program) recipients.
RWHAP funds may be used to pay for fees associated with vaccine administration and treatment of monkeypox for eligible clients, such as medical visit costs, including personal protective equipment for staff, vaccination supplies, including co-pays and deductibles for insured clients. Click here to view full announcement in PDF.
Read MoreUpdate to COVID-19 Treatment Guidelines: Changes Affecting People with HIV
February 7, 2022: The COVID-19 Treatment Guidelines Panel (the Panel) has published a revised version of the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. The Panel periodically publishes statements that provide up-to-date guidance for clinicians on various aspects of COVID-19 treatment. During this update, the information and recommendations from several recently published statements were incorporated into the…
Read MoreUpdates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
February 17, 2022: The Panel updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated section are summarized below: Mycobacterium tuberculosis Updated references and rationales. Updated drug–drug interactions. Recommended short-course, rifamycin-based, latent tuberculosis infection (LTBI) treatment regimens (3HP and 3HR) over longer isoniazid monotherapy. Clarified that, for the…
Read More